Status:
COMPLETED
Vaginal Self-sampling and Human Papillomavirus Testing in Unscreened Women
Lead Sponsor:
University Hospital, Tours
Conditions:
Cancer Cervix
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are n...
Eligibility Criteria
Inclusion
- women from 30 to 65 years old
- women living in french territorial division 37 ("Indre-et-Loire")
- women having a reported general practitioner in french territorial division 37 ("Indre-et-Loire")
Exclusion
- pap smear made in the three last years
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
3612 Patients enrolled
Trial Details
Trial ID
NCT02255084
Start Date
February 1 2015
End Date
September 1 2016
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UH Tours
Tours, Indre Et Loire, France, 37000